| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.18 | 8e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.21 | 0.0004 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |